80 FR 79347 - Agency Information Collection Activities: Submission to OMB for Review and Approval; Public Comment Request
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration Federal Register Volume 80, Issue 244 (December 21, 2015)
Health Resources and Services Administration
Federal Register Volume 80, Issue 244 (December 21, 2015)
| Page Range | 79347-79348 | |
| FR Document | 2015-31936 |
[Federal Register Volume 80, Number 244 (Monday, December 21, 2015)] [Notices] [Pages 79347-79348] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2015-31936] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration Agency Information Collection Activities: Submission to OMB for Review and Approval; Public Comment Request AGENCY: Health Resources and Services Administration, HHS. ACTION: Notice. ----------------------------------------------------------------------- SUMMARY: In compliance with Section 3507(a)(1)(D) of the Paperwork Reduction Act of 1995, the Health Resources and Services Administration (HRSA) has submitted an Information Collection Request (ICR) to the Office of Management and Budget (OMB) for review and approval. Comments submitted during the first public review of this ICR will be provided to OMB. OMB will accept further comments from the public during the review and approval period. DATES: Comments on this ICR should be received no later than January 20, 2016. ADDRESSES: Submit your comments, including the Information Collection Request Title, to the desk officer for HRSA, either by email to OIRA_submission@omb.eop.gov or by fax to 202-395-5806. FOR FURTHER INFORMATION CONTACT: To request a copy of the clearance requests submitted to OMB for review, email the HRSA Information Collection Clearance Officer at paperwork@hrsa.gov or call (301) 594- 4306. SUPPLEMENTARY INFORMATION: Information Collection Request Title: The Maternal, Infant, and Early Childhood Home Visiting Program Performance Measurement Information System. OMB No.: 0906-xxxx--NEW. Abstract: The Maternal, Infant, and Early Childhood Home Visiting Program (MIECHV), administered by HRSA in partnership with the Administration for Children and Families (ACF), supports voluntary, evidence-based home visiting services during pregnancy and to parents with young children up to kindergarten entry. States and territories (as well as nonprofit organizations selected to provide services in non-participating states and territories) are eligible to receive funding from the Home Visiting Program and have flexibility to tailor the program to serve the specific needs of their communities. Need and Proposed Use of the Information: HRSA will use the proposed information to demonstrate program accountability and continuously monitor and provide oversight to state and territory Home Visiting Program grantees. The information will also be used to provide quality improvement guidance and technical assistance to grantees and help inform the development of early childhood systems at the national, state, and local level. HRSA is seeking to collect demographic, service utilization, and select clinical indicators for participants enrolled in home visiting services. In addition, HRSA will collect a set of standardized performance and system outcome indicators that correspond with the statutorily identified benchmark areas. Demographic, Service Utilization, and Clinical Indicators Data: These data will describe the population served by the Home Visiting Program, including the unduplicated count of the number of participants and participant groups by race and ethnicity. These data will provide other socio-demographic characteristics of program participants and their utilization of services, such as program retention. Additionally, these data will describe several select clinical indicators of program participants, such as a child's usual source of medical care. This information will be collected from participants at enrollment in home visiting services and aggregated and reported to HRSA by state/ territory grantees once annually. Performance and System Outcome Benchmark Data: These data constitute a discrete set of standardized performance and system outcome indicators that correspond with the statutorily identified benchmark areas. These data will provide aggregate totals, percentages, and rates for performance and system outcome indicators that are salient to the Home Visiting Program, home visiting services more generally, and the at-risk populations served. These data will be collected from participants based on the appropriate measurement period defined for each measure and aggregated and reported to HRSA by state/ territory grantees once annually. This information will be used to demonstrate accountability with legislative and programmatic requirements. It will also be used to monitor and provide continued oversight for grantee performance and to target technical assistance resources to grantees. In the future, it is anticipated that Home Visiting Program funding decisions may be allocated based on grantee performance, including on benchmark performance areas. Likely Respondents: Home Visiting Program grantees. Burden Statement: Burden in this context means the time expended by persons to generate, maintain, retain, disclose or provide the information requested. This includes the time needed to review instructions; to develop, acquire, install and utilize technology and systems for the purpose of collecting, validating and verifying information, processing and maintaining information, and disclosing and providing information; to train personnel and to be able to respond to a collection of information; to search data sources; to complete and review the collection of information; and to transmit or otherwise disclose the information. The total annual burden hours estimated for this ICR are summarized in the table below. [[Page 79348]] Total Estimated Annualized Burden--Hours ---------------------------------------------------------------------------------------------------------------- Average Number of Number of Total burden per Total burden Form name respondents responses per responses response (in hours respondent hours) ---------------------------------------------------------------------------------------------------------------- Form 1: Demographic, Service 56 1 56 425 23,800 Utilization, and Clinical Indicators Data................ Form 2: Performance and System 56 1 56 425 23,800 Outcome Benchmark Data......... ------------------------------------------------------------------------------- Total....................... 56 .............. 56 .............. 47,600 ---------------------------------------------------------------------------------------------------------------- Jackie Painter, Director, Division of the Executive Secretariat. [FR Doc. 2015-31936 Filed 12-18-15; 8:45 am] BILLING CODE 4165-15-P
![Federal Register / Vol. 80, No. 244 / Monday, December 21, 2015 / Notices 79347
speakers for the scheduled open public ADDRESSES: Submit your comments, characteristics of program participants
hearing session. The contact person will including the Information Collection and their utilization of services, such as
notify interested persons regarding their Request Title, to the desk officer for program retention. Additionally, these
request to speak by February 2, 2016. HRSA, either by email to OIRA_ data will describe several select clinical
Persons attending FDA’s advisory submission@omb.eop.gov or by fax to indicators of program participants, such
committee meetings are advised that the 202–395–5806. as a child’s usual source of medical
Agency is not responsible for providing FOR FURTHER INFORMATION CONTACT: To care. This information will be collected
access to electrical outlets. request a copy of the clearance requests from participants at enrollment in home
FDA welcomes the attendance of the submitted to OMB for review, email the visiting services and aggregated and
public at its advisory committee HRSA Information Collection Clearance reported to HRSA by state/territory
meetings and will make every effort to Officer at paperwork@hrsa.gov or call grantees once annually.
accommodate persons with disabilities. (301) 594–4306. Performance and System Outcome
If you require accommodations due to a Benchmark Data: These data constitute
SUPPLEMENTARY INFORMATION:
disability, please contact Lee L. Information Collection Request Title: a discrete set of standardized
Zwanziger at least 7 days in advance of The Maternal, Infant, and Early performance and system outcome
the meeting. Childhood Home Visiting Program indicators that correspond with the
FDA is committed to the orderly
Performance Measurement Information statutorily identified benchmark areas.
conduct of its advisory committee
System. These data will provide aggregate totals,
meetings. Please visit our Web site at
OMB No.: 0906–xxxx—NEW. percentages, and rates for performance
http://www.fda.gov/Advisory Abstract: The Maternal, Infant, and and system outcome indicators that are
Committees/AboutAdvisoryCommittees/ Early Childhood Home Visiting Program salient to the Home Visiting Program,
ucm111462.htm for procedures on (MIECHV), administered by HRSA in home visiting services more generally,
public conduct during advisory partnership with the Administration for and the at-risk populations served.
committee meetings. Children and Families (ACF), supports
Notice of this meeting is given under These data will be collected from
voluntary, evidence-based home visiting participants based on the appropriate
the Federal Advisory Committee Act (5
services during pregnancy and to measurement period defined for each
U.S.C. app. 2).
parents with young children up to measure and aggregated and reported to
Dated: December 15, 2015. kindergarten entry. States and territories HRSA by state/territory grantees once
Jill Hartzler Warner, (as well as nonprofit organizations annually.
Associate Commissioner for Special Medical selected to provide services in non- This information will be used to
Programs. participating states and territories) are demonstrate accountability with
[FR Doc. 2015–31893 Filed 12–18–15; 8:45 am] eligible to receive funding from the legislative and programmatic
BILLING CODE 4164–01–P Home Visiting Program and have requirements. It will also be used to
flexibility to tailor the program to serve monitor and provide continued
the specific needs of their communities. oversight for grantee performance and to
DEPARTMENT OF HEALTH AND Need and Proposed Use of the target technical assistance resources to
HUMAN SERVICES Information: HRSA will use the grantees. In the future, it is anticipated
proposed information to demonstrate that Home Visiting Program funding
Health Resources and Services program accountability and
Administration decisions may be allocated based on
continuously monitor and provide grantee performance, including on
oversight to state and territory Home benchmark performance areas.
Agency Information Collection Visiting Program grantees. The
Activities: Submission to OMB for information will also be used to provide Likely Respondents: Home Visiting
Review and Approval; Public Comment quality improvement guidance and Program grantees.
Request technical assistance to grantees and help Burden Statement: Burden in this
AGENCY: Health Resources and Services inform the development of early context means the time expended by
Administration, HHS. childhood systems at the national, state, persons to generate, maintain, retain,
ACTION: Notice. and local level. HRSA is seeking to disclose or provide the information
collect demographic, service utilization, requested. This includes the time
SUMMARY: In compliance with Section and select clinical indicators for needed to review instructions; to
3507(a)(1)(D) of the Paperwork participants enrolled in home visiting develop, acquire, install and utilize
Reduction Act of 1995, the Health services. In addition, HRSA will collect technology and systems for the purpose
Resources and Services Administration a set of standardized performance and of collecting, validating and verifying
(HRSA) has submitted an Information system outcome indicators that information, processing and
Collection Request (ICR) to the Office of correspond with the statutorily maintaining information, and disclosing
Management and Budget (OMB) for identified benchmark areas. and providing information; to train
review and approval. Comments Demographic, Service Utilization, and personnel and to be able to respond to
submitted during the first public review Clinical Indicators Data: These data will a collection of information; to search
of this ICR will be provided to OMB. describe the population served by the data sources; to complete and review
OMB will accept further comments from Home Visiting Program, including the the collection of information; and to
the public during the review and unduplicated count of the number of transmit or otherwise disclose the
mstockstill on DSK4VPTVN1PROD with NOTICES
approval period. participants and participant groups by information. The total annual burden
DATES: Comments on this ICR should be race and ethnicity. These data will hours estimated for this ICR are
received no later than January 20, 2016. provide other socio-demographic summarized in the table below.
VerDate Sep<11>2014 17:38 Dec 18, 2015 Jkt 238001 PO 00000 Frm 00046 Fmt 4703 Sfmt 4703 E:\FR\FM\21DEN1.SGM 21DEN1](https://thefederalregister.org/doc/80_FR_79591/page/1.svg)
![79348 Federal Register / Vol. 80, No. 244 / Monday, December 21, 2015 / Notices
TOTAL ESTIMATED ANNUALIZED BURDEN—HOURS
Average
Number of
Number of Total burden per Total burden
Form name responses per
respondents responses response hours
respondent (in hours)
Form 1: Demographic, Service Utilization, and Clinical In-
dicators Data .................................................................... 56 1 56 425 23,800
Form 2: Performance and System Outcome Benchmark
Data .................................................................................. 56 1 56 425 23,800
Total .............................................................................. 56 ........................ 56 ........................ 47,600
Jackie Painter, fluorescence excitation and emission Inventors
Director, Division of the Executive Secretariat. peaks. The fluorescence intensity can be • Keir Neuman, Ambika Bumb, Han
[FR Doc. 2015–31936 Filed 12–18–15; 8:45 am] readily controlled by the size of the Wen, Jennifer Hong and Susanta
BILLING CODE 4165–15–P FND, the number of fluorescent centers Sarkar (all of NHLBI)
produced in the nanodiamonds, or in • Chang Yi, Lawrence Samelson, Asit
situ through the application of a weak Manna (all of NCI)
DEPARTMENT OF HEALTH AND magnetic field. The particular advantage Intellectual Property: HHS Reference
HUMAN SERVICES of the FND compositions of this No. E–217–2015/0–US–01
invention are that they are particularly • US Provisional Patent Application 62/
National Institutes of Health useful for extended imaging of a single 262,058 filed December 2, 2015.
sample over time periods that can be as Licensing Contact: Michael
Government-Owned Inventions;
long as a week or more. In an exemplary Shmilovich, Esq, CLP; 301–435–5019;
Availability for Licensing
embodiment, FNDs are immobilized in shmilovm@mail.nih.gov.
AGENCY: National Institutes of Health, a substrate that are coated with an inert Collaborative Research Opportunity:
HHS. top coating, like silicon dioxide, or The National Heart, Lung and Blood
ACTION: Notice. transparent polymer (e.g. poly-L-lysine, Institute seeks statements of capability
poly-L-arginine, or siloxanes). or interest from parties interested in
SUMMARY: The inventions listed below Generally, any suitable methods known collaborative research to further develop
are owned by an agency of the U.S. for surface functionalization of the and evaluate metallic nanoparticle
Government and are available for substrate can be used to make the vesicles for cancer phototherapy. For
licensing in the U.S. in accordance with composition. In another aspect of this collaboration opportunities, please
35 U.S.C. 209 and 37 CFR part 404 to invention, the inventors designed contact Vincent Kolesnitchenko, Ph.D.
achieve expeditious commercialization software for super-resolution imaging at kolesniv@nhlbi.nih.gov.
of results of federally-funded research correction method is employed to
and development. Foreign patent Dated: December 15, 2015.
precisely determine the position
applications are filed on selected Michael Shmilovich,
coordinates of each of a set of FNDs in
inventions to extend market coverage Senior Licensing and Patenting Manager,
a plurality of images by using Gaussian
for companies and may also be available National Heart, Lung, and Blood Institute,
fitting of the point spread function Office of Technology Transfer and
for licensing. comprises each of the FNDs in the Development.
FOR FURTHER INFORMATION CONTACT: plurality of images. The calculated [FR Doc. 2015–31890 Filed 12–18–15; 8:45 am]
Licensing information and copies of the correction is then used to displace each BILLING CODE 4140–01–P
U.S. patent applications listed below image to align the coordinates of the
may be obtained by emailing the FNDs. The positions of the FNDs can be
indicated licensing contact at the tracked with sub-nanometer precision DEPARTMENT OF HEALTH AND
National Heart, Lung, and Blood, Office and residual drift can be reduced to the HUMAN SERVICES
of Technology Transfer and nanometer scale over hundreds of hours
Development Office of Technology of tracking. National Institutes of Health
Transfer, 31 Center Drive Room 4A29,
MSC2479, Bethesda, MD 20892–2479; Potential Commercial Applications Submission for OMB Review; 30-Day
telephone: 301–402–5579. A signed • Fluorescent Microscopy Comment Request; Generic Clearance
Confidential Disclosure Agreement may • Super-resolution microscopy for the Collection of Qualitative
be required to receive copies of the • Correlative imaging techniques Feedback on Agency Service Delivery
patent applications. combing fluorescence microscopy (NIAID)
SUPPLEMENTARY INFORMATION: with electron, x-ray, or atomic force
microscopy imaging modalities SUMMARY: Under the provisions of
Technology description follows. Section 3507(a)(1)(D) of the Paperwork
Fluorescent Nanodiamonds as Fiducial Competitive Advantages Reduction Act of 1995, the National
mstockstill on DSK4VPTVN1PROD with NOTICES
Markers for Microscopy • Non-blinking, Non-bleaching Institutes of Health, has submitted to the
• Chemically inert Office of Management and Budget
Description of Technology
• Chemically and physically stable (OMB) a request for review and
The invention relates to fluorescent • Broad excitation approval of the information collection
nanodiamonds (FNDs) and their uses as • Longevity listed below. This proposed information
fiducial markers for microscopy. FNDs collection was previously published in
are bright fluorescent probes that do not Development Stage the Federal Register on October 1, 2015,
blink or bleach and have broad • In vitro data 80 FR 59168 and allowed 60-days for
VerDate Sep<11>2014 17:38 Dec 18, 2015 Jkt 238001 PO 00000 Frm 00047 Fmt 4703 Sfmt 4703 E:\FR\FM\21DEN1.SGM 21DEN1](https://thefederalregister.org/doc/80_FR_79591/page/2.svg)
Document Created: 2015-12-19 02:56:54
Document Modified: 2015-12-19 02:56:54
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice. | |
| Dates | Comments on this ICR should be received no later than January 20, 2016. | |
| Contact | To request a copy of the clearance requests submitted to OMB for review, email the HRSA Information Collection Clearance Officer at [email protected] or call (301) 594- 4306. | |
| FR Citation | 80 FR 79347 |
2024 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR